8 semaglutide Efficacy and safety of once-weekly versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial D-[Ser]-8-Semaglutide | CAS No- NA
Pay in 4 interest-free payments of $6.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
![8 semaglutide Efficacy and safety of once-weekly versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial D-[Ser]-8-Semaglutide | CAS No- NA](https://chemicea.com/admin/uploads/products/CP-S78094.png)
![8 semaglutide Efficacy and safety of once-weekly versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial D-[Ser]-8-Semaglutide | CAS No- NA](https://www.reuters.com/resizer/v2/2BKGQW46DZILHDPRFLMWLHR5U4.jpg?auth=23bd4db98e742134ac5b06edbd950f0d1b5567199927edbdbcd3d13aa6b0e4d0&width=1920&quality=80)
![8 semaglutide Efficacy and safety of once-weekly versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial D-[Ser]-8-Semaglutide | CAS No- NA](https://scx2.b-cdn.net/gfx/news/hires/2025/ozempic-4.jpg)





















